CDC Encourages Doctors to Discuss PFAS Exposure with Patients
The Centers for Disease Control and Prevention (CDC) has issued new guidance urging healthcare providers to consider expanding blood testing for per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals.”
Widespread Exposure to PFAS
Dr. Aaron Bernstein, Director of CDC’s National Center for Environmental Health, highlighted the prevalence of PFAS exposure, with over 90% of Americans affected. Communities across the country have experienced high levels of exposure, leading to increased health risks.
Potential Health Risks and Sources of Exposure
PFAS, found in various consumer products, can pose health risks such as elevated cholesterol, cancer, and pregnancy-related complications. The chemicals are commonly used in clothing, food packaging, and water-resistant surfaces.
Guidance for Healthcare Providers
The CDC recommends healthcare providers take into account a patient’s exposure history and test results from water sources or food. While blood tests may aid in exposure reduction and patient reassurance, they do not pinpoint the exact source of exposure or link it directly to health conditions.
Challenges and Future Outlook
Accessibility to blood testing for PFAS varies across the country, with costs ranging in the hundreds of dollars. The CDC emphasizes the evolving nature of PFAS research and testing, committing to updating information as needed to address the changing landscape.